Fertility: Clinical Trials

4 trials for Fertility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 1, Terminated 1
Phase 21Recruiting 1

Follow Fertility: new trials by email Literature Review of Fertility trials Research Report on Fertility

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
PD1 antibody, Medroxyprogesterone Acetate 500 MG, Megestrol Acetate 160 MG - Endometrial Cancer, Fertility
Phase 2 / Phase 3RecruitingFudan University2602026-01-252026-03-13
Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5, 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger - Fertility
Phase 3CompletedFundación Santiago Dexeus Font1942023-12-182026-06-23
A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
GONAL-f®, Luveris®, Recombinant human chorionic gonadotropin (r-hCG) - Infertility, Fertility
Phase 3TerminatedMerck KGaA, Darmstadt, Germany1742012-05-012015-11-09
Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)
Endometrin, Crinone - Fertility
Phase 3CompletedFerring Pharmaceuticals12112005-07-012011-05-19

Narrower conditions

Endometrial Neoplasms (1)  ·  Infertility (1)

Broader conditions

Genital Diseases (2)  ·  Urogenital Diseases (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Urogenital Neoplasms (1)  ·  Uterine Diseases (1)  ·  Uterine Neoplasms (1)

Interventions

Chorionic Gonadotropin (1)  ·  Crinone (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Letrozole (1)  ·  Luteinizing Hormone, beta Subunit (1)  ·  Medroxyprogesterone Acetate (1)  ·  Megestrol Acetate (1)  ·  Progesterone (1)  ·  follitropin alfa (1)  ·  follitropin beta (1)  ·  sintilimab (1)  ·  spartalizumab (1)

Sponsors

Ferring Pharmaceuticals (1)  ·  Fudan University (1)  ·  Fundación Santiago Dexeus Font (1)  ·  Merck KGaA, Darmstadt, Germany (1)

Countries

China (1)  ·  Spain (1)  ·  United Arab Emirates (1)

Results publications

PMID 42786378

NIH funding

2023 (1)